Only correctly folded and mature tRNAs can leave the nucleus and enter the cytoplasm. Surprisingly, tRNAaminoacylation has been found to occur, not only in the cytosol, but also inside the nucleus, where it may act as an additional proofreading step and facilitate the export of 'ready-to-function' aminoacyl-tRNAs.
Lund and Dahlberg [3] have now changed this view, with evidence that tRNA splicing normally occurs before endmaturation. They have further shown that correctly processed termini are required for export of tRNA from the nucleus [3] . Their most unexpected finding, however, is that tRNAs can be aminoacylated -charged with their cognate amino acids -inside the nucleus. This has a functional significance, as non-aminoacylated tRNAs are exported into the cytoplasm at a slower rate than the corresponding charged tRNAs. This importance of tRNA end-maturation for nuclear tRNA export has been independently observed by Mattaj and co-workers [4] in the course of their study of the structural requirements for binding of tRNA to its nuclear export receptor.
More than a decade ago [5] , nuclear export of tRNA was shown to be a carrier-mediated and active transport process, sensitive to mutations that destabilize the conserved tRNA tertiary structure or severely impair its processing. It was only last year, however, that a nuclear export receptor for tRNA was characterised in yeast and mammalian cells [6] [7] [8] [9] . This receptor, a member of the importin β family known as Xpo-t (Los1 in yeast), displays all the properties expected of an 'exportin' -such as association with the nuclear pores and dependence on Ran-GTP for binding to cargo molecules -but differs from the other exportins that have been characterized so far in recognizing an RNA molecule rather than a protein (for a recent review of nucleocytoplasmic transport see [10] ).
With the tRNA nuclear export receptor Xpo-t in hand, Mattaj and colleagues [4] went on to systematically characterize the structural requirements for interaction between tRNA and Xpo-t, attempting to correlate the results with the prerequisites for efficient nuclear export of tRNA. The parts of a tRNA molecule that interact directly with Xpo-t were identified by their protection against chemical modification in the Xpo-t-Ran-GTP complex; these probing experiments showed that the acceptor and TΨC arms of a tRNA molecule form the main interface with Xpo-t. A 'minihelix' consisting of these elements did not bind to Xpo-t, however; indeed, testing mutant tRNAs for binding to Xpo-t in vitro and export in vivo showed that both required correct tertiary folding, as well as mature 5′ and 3′ ends, including the addition of the CCA at the 3′ end.
These results provide an answer to the long-standing question of why pre-tRNAs with unprocessed ends or an abnormal structure cannot escape from the nucleus. These pre-tRNAs have low affinity for the export receptor and therefore no access to the nuclear export pathway. But this does not apply to unspliced pre-tRNAs: an intron-containing pre-tRNA binds as well to Xpo-t-Ran-GTP as does a mature tRNA. Nevertheless, the nuclear export of this unspliced tRNA is poor, unless excess Xpo-t is co-injected into the oocyte nucleus [4] . These observations can be explained by the recent findings of Lund and Dahlberg [3] .
Lund and Dahlberg [3] have found that when low, and therefore physiologically relevant, amounts of pre-tRNAs are injected into the oocyte nucleus, splicing is kinetically favored and occurs prior to removal of terminal sequences. Under physiological conditions, therefore, the only cargo available to the tRNA export machinery may be spliced tRNA molecules. But the tRNA splicing machinery appears to be easily saturated when large amounts of pre-tRNAs are present, leading to accumulation of unspliced, but otherwise mature, tRNAs. Only under these artificial conditions can the excess of the intron-containing tRNAs access the nuclear export machinery and thereby escape into the cytoplasm. It should, however, be kept in mind that mutant yeast cells that are defective in tRNA nuclear export, such as los1 or rna1-1 cells, accumulate intron-containing but end-matured pre-tRNAs inside the nucleus [9] . This suggests that the yeast tRNA nuclear export machinery may somehow be coupled to the splicing machinery (for further discussion see [1] ).
The observation that the tRNA export machinery accepts the presence of introns, but requires maturation at the 5′ and 3′ ends as well as attachment of the CCA 3′ terminal sequence -in other words, the formation of a functional amino acid acceptor helix -prompted Lund and Dahlberg [3] to test whether tRNAs have to be aminoacylated in order to be exported from the nucleus. Despite the fact that some components of the aminoacylation machinery have previously been detected in the nucleus (reviewed in [11] ), tRNA-aminoacylation has been thought to be a strictly cytoplasmic process. However, Lund and Dahlberg have been able to demonstrate that tRNAs injected in Xenopus oocyte nuclei are charged with their cognate amino acids before leaving the nucleus.
Lund and Dahlberg [3] found that, even under conditions where tRNA export was blocked by depletion of nuclear Ran-GTP, the injected tRNAs were aminoacylated, proving that aminoacylation was actually taking place inside the nucleus. Specific inhibitors of aminoacylation not only abolished intranuclear (in addition to cytoplasmic)
Figure 1
The tRNA biogenesis pathway, highlighting recent findings and open questions. Precursor tRNAs are transcribed in the nucleus and undergo first splicing, if they contain introns, and then processing of their 5′ and 3′ ends and CCA addition at the 3′ end. Only these resulting mature tRNAs bind with high affinity to the tRNA nuclear export receptor (Los1/Xpo-t) in the presence of Ran-GTP [4] (1). The tRNA-Xpo-t-Ran-GTP complex is translocated to the cytoplasm through the nuclear pores and, on hydrolysis of GTP, it dissociates releasing the tRNA. In the light of the recent findings of Lund and Dahlberg [3] discussed in the text, alternative pathways are possible. Mature tRNAs can be aminoacylated inside the nucleus and then delivered to the Xpo-t-Ran-GTP complex for export (2) . In this case, export of aminoacylated tRNAs is facilitated either because they have a higher affinity for Xpo-t or because their interaction with Xpo-t is stimulated by another component. Aminoacylated tRNAs may also follow a Xpo-t-independent pathway out of the nucleus (3), involving as yet unidentified factors. In the case of pathways (2) and (3), aminoacyl-tRNAs that exit the nucleus can be directly used by the protein translation machinery. Intranuclear tRNA-aminoacylation also implies that components of the aminoacylation machinery, including aminoacyl-tRNA synthetases (AARSs) and cofactors (Arc1/p43), must be imported into the nucleus, a process about which nothing is known. AA, aminoacyl-group. aminoacylation, but also led to significant retardation in the nuclear export of the non-aminoacylated tRNA [3] . Intranuclear aminoacylation of tRNA was also detected by Mattaj and co-workers [4] , who additionally found that mutant tRNAs that cannot be aminoacylated are exported from oocyte nuclei at a lower rate than wild-type tRNAs. At least one of these mutant tRNAs, however, binds to Xpo-t-Ran-GTP as efficiently as a wild-type tRNA.
How important is aminoacylation for tRNA's association with the components of the nuclear export machinery? Although the effect of aminoacylation on the interaction of a tRNA with Xpo-t has not yet been directly tested, the fact that non-aminoacylated tRNAs bind with high affinity to Xpo-t suggests that aminoacylation is not required for this interaction. Furthermore, as mentioned above, introncontaining pre-tRNAs also interact with Xpo-t and can be eventually exported from the nucleus, despite the fact that these tRNAs should be very poor substrates for their corresponding aminoacyl-tRNA synthetases [3, 4] .
Several hypotheses could explain these observations. Firstly, a small difference in the affinity of aminoacylated versus non-aminoacylated tRNAs for Xpo-t in vitro might be amplified and become significant in vivo, where a plethora of RNA species have to compete for binding to Xpo-t. Secondly, the delivery of aminoacyl-tRNAs to Xpo-t might be facilitated in vivo by the aminoacyl-tRNA synthetases or other proteins that specifically interact with charged tRNAs. Lastly, the effect of aminoacylation on nuclear export of tRNAs might not be related to their affinity for Xpo-t; there might be an additional tRNA nuclear export pathway that does not involve Xpo-t and is sensitive to the aminoacylation state of the transported tRNAs (see also Figure 1 ). Some evidence against this last possibility has come from the work of Mattaj and colleagues [4] , who found that injection of antibodies against Xpo-t into Xenopus oocyte nuclei significantly inhibited tRNA nuclear export. This observation indicates that Xpo-t is the major tRNA export receptor in Xenopus oocytes. So even if an alternative Xpo-t-independent tRNA nuclear export pathway does exist, it could play only a minor role in Xenopus oocytes. But the rapid growth of cells or organisms might conceivably demand a higher nuclear tRNA export rate, and it is very unlikely that this could be provided by simple diffusion of tRNA out of the nucleus, so an additional -and possibly tRNA-aminoacylation-dependent -export mechanism might come into operation at other developmental stages. This might especially be true for yeast, as Los1 -the Saccharomyces cerevisiae homologue of Xpo-t -is not required for cell viability.
Interestingly, Los1 does become essential for yeast cell growth if aminoacylation or translation factors, such as Arc1 or eIF-2γ, are mutated [7, 12] . Arc1, which is present mainly in the cytoplasm, associates with at least two aminoacyltRNA synthetases and promotes the efficient interaction with their cognate tRNAs; eIF-2γ is the γ subunit of eukaryotic protein translation initiation factor 2, which binds to the charged initiator tRNA Met . The genetic interaction of Arc1 and eIF-2γ with Los1 might simply reflect their involvement in transport of newly exported tRNAs to the cytosolic aminoacylation and translation machineries, respectively. But it is also possible that eIF-2γ, Arc1 or any other protein that binds to aminoacyl-tRNAs -such as elongation factor eEF-1α -might promote the nuclear export of tRNA [3] . These factors might either act in concert with Los1/Xpo-t or be components of a redundant Los1/Xpo-t-independent, but aminoacylation-dependent, nuclear tRNA export pathway (Figure 1 ).
Another issue raised by the finding of intranuclear tRNA aminoacylation is how aminoacyl-tRNA synthetases gain access to the nuclear interior. Although the structures and properties of these enzymes have been extensively investigated, with a few exceptions their subcellular location has been little studied. Indeed, the few aminoacyl-tRNA synthetases that have been immunocytologically localized were detected inside the nucleus, in addition to their predominant localization in the cytoplasm (reviewed in [11] ). One would expect that, if the twenty aminoacyl-tRNA synthetases are transported into the nucleus, then they should all contain nuclear localization sequences (NLSs). But they must not be allowed to accumulate inside the nucleus, as their major site of activity is the cytoplasm where the bulk of tRNA resides. This can be achieved by regulating the nucleocytoplasmic transport of the aminoacyl-tRNA synthetases, for example by also using nuclear export sequences (NESs) that would allow them to shuttle between nucleus and cytoplasm.
The catalytic domains of aminoacyl-tRNA synthetases are generally well conserved between prokaryotes and eukaryotes. It is possible that there might be NLSs or NESs in the non-catalytic domains or extensions that are characteristic of the eukaryotic enzymes. These domains have also been implicated in the organization of supramolecular assemblies, such as the mammalian 1100 kDa 'multisynthetase complex', which contains nine aminoacyl-tRNA synthetases as well as three non-catalytic components, one of which, p43, is the mammalian homologue of Arc1 [11, 12] . Tracking down the movement of this particle in and out of the nucleus should certainly be a challenging task for cell biologists.
In summary, the recent studies that we have reviewed suggest that, at least in Xenopus oocytes, the final step of intranuclear tRNA maturation is aminoacylation, which might act as a proofreading mechanism to ensure the structural integrity of exported tRNAs, as well as to promote their efficient transport into the cytoplasm. This unexpected finding makes us realise how much more we still have to learn about basic cellular processes, such as tRNAaminoacylation, which we thought we understood so well.
